A trial study is currently underway from Romark Laboratories to help victims of the vicious Chron's Disease.
Romark Laboratories has begun enrolling patients in a clinical trial evaluating Alinia (nitazoxanide) for treatment of mild to moderate active Crohn's disease in adults
